Claims for Patent: 6,861,243
✉ Email this page to a colleague
Summary for Patent: 6,861,243
Title: | Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
Abstract: | New genes containing a DNA sequence coding for hydroxynitrile lyase, which genes can be prepared via a primer combination based on the DNA sequence of the 5\'-region of the mdl genes from Prunus serotina and from Prunus amygdalus and/or a primer 2 based on the 3\'-region of the DNA sequences of one of the hydroxynitrile lyase isoenzymes from Prunus serotina or from Prunus amygdalus, subsequent amplification with a DNA polymerase using a DNA from organisms, containing genes coding for hydroxynitrile lyase, as templates and cloning, and also recombinant proteins which can be prepared in suitable host cells by heterologous expression of the DNA sequence of said HNL genes, and proteins and fusion proteins derived therefrom and use of said proteins for preparing (R)- or (S)-cyanohydrins. |
Inventor(s): | Schwab; Helmut (Graz, AT), Glieder; Anton (Gleisdorf, AT), Kratky; Christoph (Graz, AT), Dreveny; Ingrid (Graz, AT), Pochlauer; Peter (Linz, AT), Skranc; Wolfgang (Vienna, AT), Mayrhofer; Herbert (Engerwitzdorf, AT), Wirth; Irma (Enns, AT), Neuhofer; Rudolf (Engerwitzdorf, AT), Bona; Rodolfo (Graz, AT) |
Assignee: | DSM Fine Chemicals Austria NFG GmbH & Co. KG (Linz, AT) |
Application Number: | 10/046,232 |
Patent Claims: | 1. An isolated nucleotide sequence encoding a protein having hydroxynitrile lyase activity, wherein the nucleotide sequence is selected from the group consisting of: (1) a
nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 19; (2) a nucleotide sequence encoding a protein having the amino acid sequence of SEQ ID NO: 20; (3) a nucleotide sequence having at least 85% identity with the nucleic acid sequence
of SEQ ID NO: 19 and encoding a protein having hydroxynitrile lyase; (4) a nucleotide sequence having the nucleic acid sequence from nucleotide 13 to nucleotide 2151 of SEQ ID NO: 19 and encoding a protein having hydroxynitrile lyase; and (5) a
nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 19 without the intron regions of nucleotides 116 to nucleotide 257, nucleotide 918 to nucleotide 1120, or nucleotide 1962 to nucleotide 2077 and encoding a protein having hydroxynitrile
lyase.
2. A vector comprising the nucleotide sequence of claim 1. 3. A host cell comprising the vector of claim 2. 4. The host cell of claim 3, wherein the host cell is a microorganism cell. 5. The host cell of claim 3, wherein the host cell is Saccharomyces cerevisiae or Pichia pastoris. 6. A method for producing a protein having hydroxynitrile lyase activity comprising: culturing the host cell of claim 3, isolating the expressed protein having hydroxynitrile lyase activity from the cells, and purifying the expressed protein having hydroxynitrile lyase activity. |
Details for Patent 6,861,243
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2021-01-16 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2021-01-16 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2021-01-16 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.